JAMA Network Open:难以想象!每年因暴力行为而就诊的儿童高达150万!

2021-05-13 MedSci原创 MedSci原创

儿童和青少年可能遭受更多的攻击和暴力,包括家庭虐待,同伴攻击,性犯罪和社区暴力。

儿童和青少年可能遭受更多的攻击和暴力,包括家庭虐待,同伴攻击,性犯罪和社区暴力。据美国新罕布什尔大学公布的一项报告显示,因袭击,虐待,犯罪或其他形式的暴力行为而就诊的儿童每年将近有150万儿童,是先前数据的4。该研究结果发表在JAMA Network Open杂志上。

以往研究主要集中于大龄青年,或某些特定暴力类型的风险,如性侵犯或欺凌,并没有记录遭受暴力侵害的儿童去急诊室和其他服务机构诊疗数据。

CCO

在这项研究中,研究人员使用了来自美国全国范围内217岁的8503名儿童和青少年的代表性样本的调查信息,在2011年和2014年进行了全国性研究。通过多项青少年受害情况调查表评估了暴力暴露情况,该调查表包含有关受伤的后续问题,比如由于发生了什么事而去医院,医生办公室或某种类型的健康诊所。使用创伤症状清单幼儿创伤症状清单询问了有关过去1年的逆境以及当前的创伤症状情况。

结果发现,在两次调查的合并样本中,5187名儿童和青少年报告了遭受暴力侵害,其中45.6%(95CI43.1-48.2%)的年龄为29岁,以及54.4%(95CI51.8%) -56.9%)年龄在1017岁之间;男性为53.6%(95CI51.0-56.2%)。

因暴力就医的儿童和青少年的百分比

另外,有3.4%的儿童和青少年报告了(95CI2.6-4.4%)在其生活中接受过与暴力有关的医疗就诊。由于遭受暴力侵害而导致的过去1年的医疗访视率为1.9%(95CI1.2-2.7%),相当于140多万儿童和青少年。根据仅从急诊室获得的数据进行的先前估计是340,000次就诊,这反映出与暴力相关的儿童医疗服务严重不足。在接受过医疗就诊的患者中,年龄29岁约占33.3%。过去1年来访的儿童有较高的创伤症状水平和不利的童年经历。

总之,遭受暴力侵害的儿童和青少年中,有相当一部分得到了医疗服务。然而,对于有可能遭受暴力侵害的儿童和青少年,应采取以下几种方法:第一,医疗专业人员需要更多地了解如何为造成暴力的儿童和青少年提供帮助,不仅是治疗受伤的方法,还应为儿童及其家人提供有关保持安全的建议。第二,大部分的医疗访问都是为了治疗受伤,但有些是为了记录伤害,评估先前的暴力暴露和行为症状也很重要,尤其是在急诊室和医院环境中。

原始出处

David Finkelhor et al. Medical Treatment Following Violence Exposure in a National Sample of Children and Youth, JAMA Network Open (2021). DOI: 10.1001/jamanetworkopen.2021.9250

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1728945, encodeId=d13d1e2894596, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 15 06:25:31 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734361, encodeId=51871e343617e, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 02 03:25:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036614, encodeId=040610366141b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu May 13 18:25:31 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965273, encodeId=f8579652e368, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 13 17:58:40 CST 2021, time=2021-05-13, status=1, ipAttribution=)]
    2021-07-15 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1728945, encodeId=d13d1e2894596, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 15 06:25:31 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734361, encodeId=51871e343617e, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 02 03:25:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036614, encodeId=040610366141b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu May 13 18:25:31 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965273, encodeId=f8579652e368, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 13 17:58:40 CST 2021, time=2021-05-13, status=1, ipAttribution=)]
    2022-02-02 canlab
  3. [GetPortalCommentsPageByObjectIdResponse(id=1728945, encodeId=d13d1e2894596, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 15 06:25:31 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734361, encodeId=51871e343617e, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 02 03:25:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036614, encodeId=040610366141b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu May 13 18:25:31 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965273, encodeId=f8579652e368, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 13 17:58:40 CST 2021, time=2021-05-13, status=1, ipAttribution=)]
    2021-05-13 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1728945, encodeId=d13d1e2894596, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jul 15 06:25:31 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734361, encodeId=51871e343617e, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Wed Feb 02 03:25:31 CST 2022, time=2022-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036614, encodeId=040610366141b, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu May 13 18:25:31 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965273, encodeId=f8579652e368, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 13 17:58:40 CST 2021, time=2021-05-13, status=1, ipAttribution=)]
    2021-05-13 jyzxjiangqin

    好文章!

    0

相关资讯

BJU Int:COVID-19大流行的第一次冲击对肾癌三级转诊中心的影响

最近,有研究人员分析了COVID-19大流行对中心专科肾癌治疗途径的影响。

盘点:近期鼻炎与治疗进展(六)

【1】ORL J Otorhinolaryngol Relat Spec:鼻腔细胞学在射频鼻甲缩小术中的应用

盘点:近期听力损失与治疗进展(六)

【1】JCI Insight:VEGF-A165基因治疗可改善血-迷路屏障破裂和听力损失

盘点:前列腺癌与治疗进展(六)

【1】Prostate:沙利度胺抑制人前列腺基质细胞生长和平滑肌收缩:LUTS的新疗法?

J Sex Med:人脐带血单核细胞对持续性勃起功能障碍的有益影响

人脐带血(HUCB)用于基于干细胞的治疗,对5-α还原酶抑制剂(5ARI)治疗后勃起功能障碍(PPED)的影响尚未研究。

PLoS One:强直性脊柱炎患者的治疗现状选择

在韩国,目前还未有关于强直性脊柱炎(AS)患者治疗现状选择的研究。近日,研究人员利用一个全国性的数据库评估了强直性脊柱炎治疗趋势的现状,研究结果已发表于PLoS One。